Two representative MS/MS spectra of identified peptides were shown. (TIF) Post-mortem spinal cord tissues used in the present study.Age-matched postmortem spinal cords were dissected within 48 hours. studies demonstrate that acetylation of the proteins additional to GFAP is differently regulated, suggesting that acetylation and/or deacetylation play an important role in pathogenesis of ALS. == Introduction == Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that typically leads to progressive paralysis and death within a few years of onset. However, the mechanism underlying the selective motor PS-1145 neuron degeneration of ALS has remained elusive. Several toxic mechanisms have been reported, including protein misfolding and aggregation[1][3], oxidative stress[4][6], glutamate excitotoxicity[2],[7][10], neuro-inflammation[11][13], mitochondrial dysfunction, and different environmental and/or genetic factors that lead to selective motor neuron damage[14][21]. These diverse toxic mechanisms may contribute to non-cell autonomous motor PS-1145 neuron damage[22], or toxicity by non-neuronal glial cells such as astrocytes and microglia[22]. Interestingly, toxicity incurred directly within motor neurons is a central contributor to disease initiation, but only a minor contributor to disease progression[23]. Conversely, toxicity incurred in non-neuronal neighboring cells may amplify the initial insult and drives rapid disease progression, but may not be sufficient to initiate the disease[23][27]. The precise cause of most ALS is still largely unknown. A well-known hereditary factor is the genetic abnormality on chromosome 21 coding for copper-zinc superoxide dismutase (SOD1), which is associated with approximately 20% of familial cases of ALS or 2% of all ALS cases. Recent reports demonstrate mutations over PS-1145 a dozen of different proteins (TDP-43, TAR DNA-binding protein 43; FUS, Fused in Sarcoma; Ubiquilin-2, etc.) from ALS patients[14],[28][31]. The high degree of mutations found in apparently sporadic ALS cases without family history suggests that genetics plays a more significant role than previously speculated. Markedly, protein Rabbit polyclonal to ZCCHC12 aggregation is found as a pathological hallmark for all ALS and a common feature for many neurodegenerative diseases such as Alzheimer and Parkinson diseases[32],[33]. Because the insoluble protein aggregate is found just before or at the same time that ALS symptoms begin, it can be at least one of the causes for diverse neurotoxic responses. The SOD1 mutation is sufficient to induce non-cell autonomous motor neuron killing by an unknown gain of toxicity[8],[24],[34]. Further studies demonstrate that the dominant SOD1 mutant is misfolded and aggregated into cytoplasmic inclusion bodies[34][37]. SOD1 aggregation into insoluble complexes is also an early event in the pathogenic process[25], suggesting that SOD1 aggregation contributes to the toxic responses. These observations imply that the common motor neuron toxicity in ALS may be associated with the abnormal protein aggregation or any cause that leads to accumulation of aggregates or blockage of PS-1145 aggregate clearance. Notably, expression of the aggregation-prone mutant SOD1 has been recently demonstrated to promote tubulin PS-1145 acetylation, suggesting that HDAC6 impairment might be a common feature in various subtypes of ALS[38]. Indeed, HDAC inhibitors have been discovered as potential neuroprotective agents for the treatment of neurodegenerative disorders including ALS[39][42]. However, a major limitation lies in the broad spectrum of toxic side effects and even adverse effects. We hypothesize that the toxic side effects are due to the non-specificity of the HDAC inhibitors that may change the acetylation status of yet undefined substrates of deacetylases and/or products of acetylases, particularly in the insoluble protein aggregates relevant to the pathogenesis of ALS. In this study, we report protein acetylation recording in post-mortem spinal cord tissues with or without ALS using tandem mass spectrometry. == Materials and Methods == == Ethics Statement == This study involved human post-mortem tissues requested from the VA Biorepository ALS Brain Bank (CSP501) under our institutional IRB guidelines in accordance.